The Download: perimenopause misinformation and China's latest AI leap
China has released the world's largest open AI model, potentially narrowing the gap with US tech giants. Meanwhile, misinformation surrounding perimenopause is rampant, with many unproven treatments being marketed.
Intelligence analysis by Gemini 2.5 Flash Lite

This edition of The Download covers two significant developments: China's advancement in AI with the release of a large open-source model, and the concerning spread of misinformation regarding perimenopause, highlighting the need for scientifically-backed health information.
Imagine two big races. One is about building the smartest computer brains (AI), and China just showed off a really big one that anyone can use! The other race is about understanding women's bodies as they get older. Some people are spreading wrong ideas about this, like saying there's a special test for it when there isn't, and suggesting treatments that don't really work. It's important to get real information, like from a doctor, for both races.
Analysis
China's AI Ambitions Take a Leap
China's recent unveiling of the world's largest open AI model marks a significant stride in its pursuit of AI leadership, directly challenging established players like OpenAI and Anthropic. This development, reported by Reuters and Gizmodo, suggests that the perceived AI gap between China and the United States may be narrowing. The launch has already had a palpable effect on the market, with AI and semiconductor stocks experiencing a downturn, as noted by Bloomberg. This indicates investor concern and a potential shift in market dynamics as China's capabilities become more apparent.
Furthermore, the strategic importance of open-source AI is being amplified by China's leadership. As highlighted by MIT Technology Review, the country is heavily investing in and promoting open-source initiatives. This approach not only fosters rapid development and wider adoption but also positions China as a key player and potential standard-setter in the global AI landscape. President Xi Jinping's pitch of China as an AI partner to developing nations, as reported by CNBC, further underscores this ambition to lead and influence the international AI community.
The Perils of Perimenopause Misinformation
Beyond the technological advancements, the newsletter also shines a light on a critical societal issue: the rampant misinformation surrounding perimenopause. While conversations about this phase of life are becoming more open, thanks to increased visibility from media personalities and influencers, the information shared is often inaccurate or unsubstantiated. The article points out a key concern: there is no definitive test for perimenopause, despite marketing claims to the contrary. This lack of scientific grounding means that many suggested treatments and symptom explanations may lack evidence.
This surge in misinformation can have serious consequences for women seeking reliable health guidance. The piece suggests that not all symptoms experienced during midlife are solely attributable to hormonal changes, implying that a broader medical perspective is often needed. The proliferation of unverified claims and treatments can lead to delayed or incorrect diagnoses, ineffective interventions, and undue anxiety for individuals navigating this significant life transition. The need for evidence-based information and critical evaluation of health advice is paramount.
Key points
- China has launched the world's largest open AI model, potentially closing the gap with US AI leaders.
- The launch of China's AI model has impacted AI and semiconductor stock prices.
- China is strategically leveraging open-source AI to bolster its global standing in the field.
- Misinformation about perimenopause is widespread, with many unproven treatments being marketed.
- There is no scientifically validated test for perimenopause, despite claims to the contrary.
China's push for open-source AI could accelerate global innovation and provide more accessible tools for researchers and developers worldwide. Increased openness in discussing perimenopause, despite current misinformation, may eventually lead to greater awareness and demand for scientifically-backed solutions and support for women's health.
China's rapid AI advancements could intensify geopolitical competition and raise concerns about technological dominance and security. The continued spread of perimenopause misinformation could lead to widespread misdiagnosis, ineffective treatments, and a decline in trust in legitimate medical advice.


